PsygaBio is a drug discovery company focused on developing groundbreaking therapeutics derived from natural compounds. Founded by world-renowned cannabis and mushrooms researcher and pioneer Prof. Dedi Meiri from the Technion – Israel Institute of Technology and backed by robust scientific capabilities. Psyga Bio using Cannasoul’s proprietary analytical platform, data-driven approach, unique knowhow and clinical trial framework supports active compound identification and development, from mushrooms cultivation and extraction through clinical approved formulations.
